What does Cellcarta do?
CellCarta is a leading provider of specialized services in the field of precision medicine. The company focuses on advanced cellular analysis and biomarker development to support drug discovery and development. Their expertise helps pharmaceutical and biotechnology companies accelerate their research and improve patient outcomes.
- Sectors
- Education and training
- Signals
-
ProfitableProfitable € 7.70M
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 25.87MStrong equity provides a buffer against setbacks.
Low riskLow risk 42.8%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 10.34MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 14.36MPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 79.88MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 16.2%Social debts stay manageable relative to personnel costs.
- Shareholders
- Histogenex Holding 83,33%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
79.88M
|
€
74.03M
|
€
58.62M
|
€
53.08M
|
|
|
€
14.36M
|
€
12.88M
|
€
5.18M
|
€
6.37M
|
|
|
€
7.70M
|
€
8.79M
|
€
860K
|
€
-7.60M
|
|
|
€
25.87M
|
€
18.17M
|
€
9.37M
|
€
8.51M
|
|
|
42.77%
|
31.38%
|
18.76%
|
19.21%
|
|
|
€
34.61M
|
€
39.72M
|
€
40.60M
|
€
35.81M
|
|
|
€
8.59M
|
€
16.49M
|
€
10.34M
|
€
6.42M
|
|
|
246.10
|
240.20
|
222.20
|
218.50
|
Publications 43
All publications- Ontslagen - Benoemingen 11/08/2026
- Ontslagen - Benoemingen 12/01/2026
- Kapitaal - Aandelen - Ontslagen - Benoemingen 03/06/2025
- Ontslagen - Benoemingen 09/10/2024
- Ontslagen - Benoemingen 06/12/2023
Frequently asked questions
Answers to the most common questions about Cellcarta, based on official government data and the filed annual accounts.
What is the VAT number of Cellcarta?
The VAT number of Cellcarta is BE0474.654.355.
How many employees work at Cellcarta?
In 2025, Cellcarta employed 246.10 full-time equivalents (FTE).
When was Cellcarta established?
Cellcarta was founded in 23-04-2001.
What is the official address of Cellcarta?
The official address of Cellcarta is Sint-Bavostraat 78 Antwerpen 2610.
What is the legal form of Cellcarta?
The juridical form of Cellcarta is Public limited company (NV/SA).
What is the annual revenue of Cellcarta?
The revenue of Cellcarta for the 2025 financial year was €79,878,333.
What does Cellcarta do?
CellCarta is a leading provider of specialized services in the field of precision medicine. The company focuses on advanced cellular analysis and biomarker development to support drug discovery and development. Their expertise helps pharmaceutical and biotechnology companies accelerate their research and improve patient outcomes.
Is Cellcarta a reliable company?
Cellcarta is a registered Rechtspersoon with company number 0474.654.355 and can be verified through the official CBE database.
What is the credit limit of Cellcarta?
The estimated credit limit of Cellcarta is €10,000,000.
Is Cellcarta still active?
Cellcarta currently has the status "Normal situation" and is active.